{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:02:22Z","timestamp":1792000942368,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glioblastoma (GBM) is a type of brain cancer with high morbidity and mortality worldwide. The clinical significance, biological roles, and underlying molecular mechanisms of DNA poly \u03b5-B subunit (POLE2) in GBM were investigated in the study. Firstly, the Cancer Genome Atlas (TCGA) database found that POLE2 was highly expressed in GBM. Immunohistochemistry (IHC) results further confirmed that POLE2 was abnormally elevated in GBM. In addition, loss-of-function assays revealed that POLE2 knockdown could inhibit the malignant behaviors of GBM, especially reduce cell viability, weaken cell clone formation, enhance the sensitivity of apoptosis, restrain migration and inhibit epithelial-mesenchymal transition (EMT) in vitro. In vivo experiments further clarified the suppressive effects of reduced POLE2 expression on tumors. Mechanically, POLE2 knockdown promoted the ubiquitination as well as reduced the stability of Forkhead transcription factor (FOXM1), which is a known tumor promotor in GBM, through Aurora kinase A (AURKA). Moreover, the knockdown of FOXM1 could weaken the promoting effects of POLE2 on malignant behaviors of GBM. In conclusion, our study revealed crucial roles and a novel mechanism of POLE2 involved in GBM through AURKA-mediated stability of FOXM1 and may provide the theoretical basis of molecular therapy for GBM.<\/jats:p>","DOI":"10.1038\/s41419-021-04498-7","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T08:24:30Z","timestamp":1642407870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["POLE2 facilitates the malignant phenotypes of glioblastoma through promoting AURKA-mediated stabilization of FOXM1"],"prefix":"10.1038","volume":"13","author":[{"given":"Peng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-6133","authenticated-orcid":false,"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LingYun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhengQian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"4498_CR1","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.amjmed.2017.12.039","volume":"131","author":"JR McFaline-Figueroa","year":"2018","unstructured":"McFaline-Figueroa JR, Lee EQ. Brain tumors. Am J Med. 2018;131:874\u201382.","journal-title":"Am J Med"},{"key":"4498_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s13311-017-0519-x","volume":"14","author":"R Chen","year":"2017","unstructured":"Chen R, Smith-Cohn M, Cohen AL, Colman H. Glioma subclassifications and their clinical significance. Neurotherapeutics. 2017;14:284\u201397.","journal-title":"Neurotherapeutics."},{"key":"4498_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcancer.2017.11.010","volume":"51","author":"O Gusyatiner","year":"2018","unstructured":"Gusyatiner O, Hegi ME. Glioma epigenetics: from subclassification to novel treatment options. Semin Cancer Biol. 2018;51:50\u20138.","journal-title":"Semin Cancer Biol"},{"key":"4498_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10143-016-0709-8","volume":"40","author":"NA Bush","year":"2017","unstructured":"Bush NA, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurg Rev. 2017;40:1\u201314.","journal-title":"Neurosurg Rev"},{"key":"4498_CR5","doi-asserted-by":"publisher","first-page":"xiii","DOI":"10.1016\/j.nec.2018.10.001","volume":"30","author":"GM McKhann","year":"2019","unstructured":"McKhann GM, Duffau H. Low-grade glioma: epidemiology, pathophysiology, clinical features, and treatment. Neurosurg Clin N. Am. 2019;30:xiii\u2013xiv.","journal-title":"Neurosurg Clin N. Am"},{"key":"4498_CR6","first-page":"424","volume":"24","author":"L Xiong","year":"2019","unstructured":"Xiong L, Wang F, Qi Xie X. Advanced treatment in high-grade gliomas. J BUON. 2019;24:424\u201330.","journal-title":"J BUON"},{"key":"4498_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"4498_CR8","doi-asserted-by":"crossref","unstructured":"Rajaratnam V, Islam MM, Yang M, Slaby R, Ramirez HM, Mirza SP. Glioblastoma: pathogenesis and current status of chemotherapy and other novel treatments. Cancers. 2020;12:937.","DOI":"10.3390\/cancers12040937"},{"key":"4498_CR9","first-page":"287","volume":"5","author":"Q Zhou","year":"2008","unstructured":"Zhou Q, Effati R, Talvinen K, Pospiech H, Syvaoja JE, Collan Y. Genomic changes of the 55 kDa subunit of DNA polymerase epsilon in human breast cancer. Cancer Genomics Proteom. 2008;5:287\u201392.","journal-title":"Cancer Genomics Proteom"},{"key":"4498_CR10","first-page":"923","volume":"14","author":"M Foiani","year":"1994","unstructured":"Foiani M, Marini F, Gamba D, Lucchini G, Plevani P. The B subunit of the DNA polymerase alpha-primase complex in Saccharomyces cerevisiae executes an essential function at the initial stage of DNA replication. Mol Cell Biol. 1994;14:923\u201333.","journal-title":"Mol Cell Biol"},{"key":"4498_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrg2345","volume":"9","author":"LA Loeb","year":"2008","unstructured":"Loeb LA, Monnat RJ Jr. DNA polymerases and human disease. Nat Rev Genet. 2008;9:594\u2013604.","journal-title":"Nat Rev Genet"},{"key":"4498_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.4185","volume":"230","author":"S Briggs","year":"2013","unstructured":"Briggs S, Tomlinson I. Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol. 2013;230:148\u201353.","journal-title":"J Pathol"},{"key":"4498_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ejhg.2010.216","volume":"19","author":"R Yoshida","year":"2011","unstructured":"Yoshida R, Miyashita K, Inoue M, Shimamoto A, Yan Z, Egashira A, et al. Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer. Eur J Hum Genet. 2011;19:320\u20135.","journal-title":"Eur J Hum Genet"},{"key":"4498_CR14","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1093\/hmg\/ddt131","volume":"22","author":"DN Church","year":"2013","unstructured":"Church DN, Briggs SE, Palles C, Domingo E, Kearsey SJ, Grimes JM, et al. DNA polymerase epsilon and delta exonuclease domain mutations in endometrial cancer. Hum Mol Genet. 2013;22:2820\u20138.","journal-title":"Hum Mol Genet"},{"key":"4498_CR15","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1200\/JCO.2007.12.0410","volume":"26","author":"E Hartmann","year":"2008","unstructured":"Hartmann E, Fernandez V, Moreno V, Valls J, Hernandez L, Bosch F, et al. Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. J Clin Oncol. 2008;26:4966\u201372.","journal-title":"J Clin Oncol"},{"key":"4498_CR16","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3892\/ijo.2014.2510","volume":"45","author":"D Liu","year":"2014","unstructured":"Liu D, Zhang XX, Xi BX, Wan DY, Li L, Zhou J, et al. Sine oculis homeobox homolog 1 promotes DNA replication and cell proliferation in cervical cancer. Int J Oncol. 2014;45:1232\u201340.","journal-title":"Int J Oncol"},{"key":"4498_CR17","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.7314\/APJCP.2015.16.8.3543","volume":"16","author":"AR Zekri","year":"2015","unstructured":"Zekri AR, Hassan ZK, Bahnassy AA, Khaled HM, El-Rouby MN, Haggag RM, et al. Differentially expressed genes in metastatic advanced Egyptian bladder cancer. Asian Pac J Cancer Prev. 2015;16:3543\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4498_CR18","first-page":"2477","volume":"40","author":"J Li","year":"2018","unstructured":"Li J, Wang J, Yu J, Zhao Y, Dong Y, Fan Y, et al. Knockdown of POLE2 expression suppresses lung adenocarcinoma cell malignant phenotypes in vitro. Oncol Rep. 2018;40:2477\u201386.","journal-title":"Oncol Rep."},{"key":"4498_CR19","doi-asserted-by":"publisher","first-page":"e0211737","DOI":"10.1371\/journal.pone.0211737","volume":"14","author":"A Pearlman","year":"2019","unstructured":"Pearlman A, Rahman MT, Upadhyay K, Loke J, Ostrer H. Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions. PLoS ONE. 2019;14:e0211737.","journal-title":"PLoS ONE"},{"key":"4498_CR20","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1158\/0008-5472.CAN-19-1372","volume":"80","author":"RF Rogers","year":"2020","unstructured":"Rogers RF, Walton MI, Cherry DL, Collins I, Clarke PA, Garrett MD, et al. CHK1 inhibition is synthetically lethal with loss of B-family DNA polymerase function in human lung and colorectal cancer cells. Cancer Res. 2020;80:1735\u201347.","journal-title":"Cancer Res"},{"key":"4498_CR21","doi-asserted-by":"publisher","first-page":"e921430","DOI":"10.12659\/MSM.921430","volume":"26","author":"Z Wu","year":"2020","unstructured":"Wu Z, Wang YM, Dai Y, Chen LA. POLE2 serves as a prognostic biomarker and is associated with immune infiltration in squamous cell lung cancer. Med Sci Monit. 2020;26:e921430.","journal-title":"Med Sci Monit"},{"key":"4498_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01477-4","volume":"20","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Chen G, Song Y, Chen Z, Chen X. POLE2 knockdown reduce tumorigenesis in esophageal squamous cells. Cancer Cell Int. 2020;20:388.","journal-title":"Cancer Cell Int"},{"key":"4498_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000152408","volume":"21","author":"G Beckman","year":"1971","unstructured":"Beckman G, Beckman L, Ponten J, Westermark B. G-6-PD and PGM phenotypes of 16 continuous human tumor cell lines. Evidence against cross-contamination and contamination by HeLa cells. Hum Hered. 1971;21:238\u201341.","journal-title":"Hum Hered"},{"key":"4498_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1699-0463.1968.tb03502.x","volume":"74","author":"J Ponten","year":"1968","unstructured":"Ponten J, Macintyre EH. Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand. 1968;74:465\u201386.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"4498_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-4939-7033-9_17","volume":"1615","author":"JS Lin","year":"2017","unstructured":"Lin JS, Lai EM. Protein-protein interactions: co-immunoprecipitation. Methods Mol Biol. 2017;1615:211\u20139.","journal-title":"Methods Mol Biol"},{"key":"4498_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pharmthera.2015.01.004","volume":"150","author":"L Li","year":"2015","unstructured":"Li L, Li W. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation. Pharm Ther. 2015;150:33\u201346.","journal-title":"Pharm Ther"},{"key":"4498_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/1878-0261.12017","volume":"11","author":"KT Yeung","year":"2017","unstructured":"Yeung KT, Yang J. Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol. 2017;11:28\u201339.","journal-title":"Mol Oncol"},{"key":"4498_CR28","doi-asserted-by":"publisher","first-page":"108725","DOI":"10.1016\/j.cbi.2019.108725","volume":"309","author":"C Kishore","year":"2019","unstructured":"Kishore C, Sundaram S, Karunagaran D. Vitamin K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling pathway in human colorectal cancer cells. Chem Biol Interact. 2019;309:108725.","journal-title":"Chem Biol Interact"},{"key":"4498_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2088-8","volume":"17","author":"B Li","year":"2019","unstructured":"Li B, Cheng J, Wang H, Zhao S, Zhu H, Li C, et al. CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial-mesenchymal transition. J Transl Med. 2019;17:336.","journal-title":"J Transl Med"},{"key":"4498_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s12094-017-1774-3","volume":"20","author":"C Yang","year":"2018","unstructured":"Yang C, Zhang J, Ding M, Xu K, Li L, Mao L, et al. Ki67 targeted strategies for cancer therapy. Clin Transl Oncol. 2018;20:570\u20135.","journal-title":"Clin Transl Oncol"},{"key":"4498_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2019.01.011","volume":"491","author":"SS Menon","year":"2019","unstructured":"Menon SS, Guruvayoorappan C, Sakthivel KM, Rasmi RR. Ki-67 protein as a tumour proliferation marker. Clin Chim Acta. 2019;491:39\u201345.","journal-title":"Clin Chim Acta"},{"key":"4498_CR32","doi-asserted-by":"publisher","first-page":"6442","DOI":"10.1111\/jcmm.14538","volume":"23","author":"N Yang","year":"2019","unstructured":"Yang N, Wang C, Wang J, Wang Z, Huang D, Yan M, et al. Aurora kinase A stabilizes FOXM1 to enhance paclitaxel resistance in triple-negative breast cancer. J Cell Mol Med. 2019;23:6442\u201353.","journal-title":"J Cell Mol Med"},{"key":"4498_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0482-4","volume":"9","author":"C Zhang","year":"2018","unstructured":"Zhang C, Han X, Xu X, Zhou Z, Chen X, Tang Y, et al. FoxM1 drives ADAM17\/EGFR activation loop to promote mesenchymal transition in glioblastoma. Cell Death Dis. 2018;9:469.","journal-title":"Cell Death Dis"},{"key":"4498_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/364412a0","volume":"364","author":"KL Clark","year":"1993","unstructured":"Clark KL, Halay ED, Lai E, Burley SK. Co-crystal structure of the HNF-3\/fork head DNA-recognition motif resembles histone H5. Nature. 1993;364:412\u201320.","journal-title":"Nature."},{"key":"4498_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/ncb0205-108","volume":"7","author":"RH Costa","year":"2005","unstructured":"Costa RH. FoxM1 dances with mitosis. Nat Cell Biol. 2005;7:108\u201310.","journal-title":"Nat Cell Biol"},{"key":"4498_CR36","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ncb1217","volume":"7","author":"J Laoukili","year":"2005","unstructured":"Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol. 2005;7:126\u201336.","journal-title":"Nat Cell Biol"},{"key":"4498_CR37","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1158\/0008-5472.CAN-04-4059","volume":"65","author":"DR Wonsey","year":"2005","unstructured":"Wonsey DR, Follettie MT. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res. 2005;65:5181\u20139.","journal-title":"Cancer Res"},{"key":"4498_CR38","first-page":"2129","volume":"61","author":"H Okabe","year":"2001","unstructured":"Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 2001;61:2129\u201337.","journal-title":"Cancer Res"},{"key":"4498_CR39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3892\/or.2020.7845","volume":"45","author":"DW Lee","year":"2021","unstructured":"Lee DW, Lee W, Kwon M, Lee HN. Dual inhibition of FOXM1 and its compensatory signaling pathway decreased the survival of ovarian cancer cells. Oncol Rep. 2021;45:390\u2013400.","journal-title":"Oncol Rep."},{"key":"4498_CR40","doi-asserted-by":"publisher","first-page":"108349","DOI":"10.1016\/j.abb.2020.108349","volume":"685","author":"HL Sun","year":"2020","unstructured":"Sun HL, Men JR, Liu HY, Liu MY, Zhang HS. FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner. Arch Biochem Biophys. 2020;685:108349.","journal-title":"Arch Biochem Biophys"},{"key":"4498_CR41","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jid.2017.01.021","volume":"137","author":"JA Puig-Butille","year":"2017","unstructured":"Puig-Butille JA, Vinyals A, Ferreres JR, Aguilera P, Cabre E, Tell-Marti G, et al. AURKA overexpression is driven by FOXM1 and MAPK\/ERK activation in melanoma cells harboring BRAF or NRAS mutations: impact on melanoma prognosis and therapy. J Invest Dermatol. 2017;137:1297\u2013310.","journal-title":"J Invest Dermatol"},{"key":"4498_CR42","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1038\/onc.2016.490","volume":"36","author":"N Yang","year":"2017","unstructured":"Yang N, Wang C, Wang Z, Zona S, Lin SX, Wang X, et al. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells. Oncogene. 2017;36:3428\u201340.","journal-title":"Oncogene."},{"key":"4498_CR43","doi-asserted-by":"crossref","unstructured":"Nakamura N. Ubiquitin System. Int J Mol Sci. 2018;19:1080.","DOI":"10.3390\/ijms19041080"},{"key":"4498_CR44","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20:1242\u201353.","journal-title":"Nat Med"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04498-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:59:09Z","timestamp":1669301949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04498-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["4498"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04498-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"24 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}